Published in
Elsevier, Gastroenterology, 5(154), p. 1343-1351.e1, 2018
DOI: 10.1053/j.gastro.2018.01.004
Links
Tools
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
Journal article published in 2018 by
Geert D’Haens 
,
Severine Vermeire,
Guy Lambrecht,
Filip Baert,
Peter Bossuyt,
Benjamin Pariente,
Anthony Buisson ,
Yoram Bouhnik,
Jérôme Filippi,
Janneke vander Woude,
Philippe Van Hootegem ,
Jacques Moreau,
Edouard Louis,
Denis Franchimont,
Martine De Vos
and other authors.
,
Severine Vermeire,
Guy Lambrecht,
Filip Baert,
Peter Bossuyt,
Benjamin Pariente,
Anthony Buisson ,
Yoram Bouhnik,
Jérôme Filippi,
Janneke vander Woude,
Philippe Van Hootegem ,
Jacques Moreau,
Edouard Louis,
Denis Franchimont,
Martine De Vos
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 